LFP-based Parameter Prediction in DBS for Parkinson's Disease
Assessing the Relation Between Subcortical LFPs and DBS Parameter Selection in Parkinson's Disease - a Prospective Study
1 other identifier
observational
40
1 country
1
Brief Summary
The goal of this observational study is to assess whether deep brain stimulation (DBS) contact selection in Parkinson's disease could be informed by subcortical local field potential (LFP) recordings. The main question it aims to answer is: Aligns stimulation contact selection based on subcortical LFP recordings with clinically optimized contact selection? Participants will undergo LFP recordings that are part of standard clinical care during their routine hospital visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2026
CompletedFirst Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
March 20, 2026
March 1, 2026
3 years
March 16, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Alignment of contact selection
Alignment between local field potential-based contact selection and the clinically optimized stimulation contact.
From the first LFP recording to the last LFP recording (6 - 9 months)
Eligibility Criteria
Patients with Parkinson's disease who are eligible for deep brain stimulation to treat refractory motor symptoms.
You may qualify if:
- Voluntary written informed consent of the participant
- At least 18 years of age at the time of signing the Informed Consent Form (ICF)
- Diagnosis of idiopathic Parkinson's disease according to the clinical diagnostic criteria of the Movement Disorder Society (MDS)
- Eligible for DBS to treat refractory PD motor symptoms, as based on multidisciplinary DBS screening
- Have sufficient understanding of the Dutch and French language to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loes Laurijssenlead
Study Sites (1)
University Hospitals Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
March 5, 2026
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
March 1, 2029
Last Updated
March 20, 2026
Record last verified: 2026-03